4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000239
Chairman, CEO & President sold 6,000 shares at an average $549.22 ($3,295,334)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −999 | $545.84 | $545,294 | 95,706 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −1,246 | $546.71 | $681,205 | 94,460 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −939 | $547.76 | $514,344 | 93,521 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −681 | $548.71 | $373,668 | 92,840 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −120 | $549.95 | $65,994 | 92,720 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −851 | $550.93 | $468,839 | 91,869 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −200 | $553.14 | $110,628 | 91,669 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −350 | $554.73 | $194,154 | 91,319 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-10-15 | Sale | −614 | $555.71 | $341,208 | 90,705 | D |
| Open-market sales · 6,000 sh · avg $549.22 · $3,295,334 | |||||||
Loading xslF345X03/edgardoc.xml…